Evidence map›Paper›PMID 31831627›Full record

ArticleGenes & development2020

Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth.

Ja Hyun Koo, Steven W Plouffe, Zhipeng Meng, Da-Hye Lee, Di Yang, Dae-Sik Lim, Cun-Yu Wang, Kun-Liang Guan

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.

  1. The Hippo signalling pathway and its impact on eye diseases.Journal of cellular and molecular medicine · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ja Hyun KooDepartment of Pharmacology, Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.ORCID 0000-0001-5738-1105
Steven W PlouffeDepartment of Pharmacology, Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.ORCID 0000-0002-6411-3130
Zhipeng MengDepartment of Pharmacology, Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
Da-Hye LeeNational Creative Research Initiatives Center for Cell Division and Differentiation, Department of Biological Science, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.ORCID 0000-0003-0580-9573
Di YangDepartment of Pharmacology, Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
Dae-Sik LimNational Creative Research Initiatives Center for Cell Division and Differentiation, Department of Biological Science, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
Cun-Yu WangDivision of Oral Biology and Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA.
Kun-Liang GuanDepartment of Pharmacology, Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.ORCID 0000-0003-1892-0174
University of California San Diego · USKorea Advanced Institute of Science and Technology · KRUniversity of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
Molecular and Genetic Determinants of Invasion in HNSCCR01DE015964 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, CUN-YU · 2004 to 2019
$6.6M
The mTOR and Hippo pathway in cell growth and cancerR35CA196878 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUAN, KUN-LIANG · 2015 to 2019
$4.0M
Molecular Mechanism and Therapy for Ocular MelanomaR01CA217642 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER · 2017 to 2022
$2.4M
NCI NIH HHS P30 CA016042NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA217642NCI NIH HHS R35 CA196878NIDCR NIH HHS R01 DE015964
6 · The paper itself

Abstract

Yes-associated protein (YAP) and its homolog transcriptional coactivator with PDZ-binding motif (TAZ) are key effectors of the Hippo pathway to control cell growth and organ size, of which dysregulation yields to tumorigenesis or hypertrophy. Upon activation, YAP/TAZ translocate into the nucleus and bind to TEAD transcription factors to promote transcriptional programs for proliferation or cell specification. Immediate early genes, represented by AP-1 complex, are rapidly induced and control later-phase transcriptional program to play key roles in tumorigenesis and organ maintenance. Here, we report that YAP/TAZ directly promote

Indexed as

Gene Expression Regulation, NeoplasticAdaptor Proteins, Signal TransducingAnimalsCell Line, TumorCell ProliferationGene DeletionGenes, fosHEK293 CellsHumansLiverMelanomaMiceMitogensOrgan SizePromoter Regions, GeneticTrans-ActivatorsAdaptor Proteins, Signal TransducingMitogensTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsTranscription Factor AP-1Transcription FactorsWWTR1 protein, humanYAP1 protein, humanYAP-Signaling Proteinsbilirubincancerc-foshepatomegalyHippoliver

Identifiers

PMID31831627
PMCPMC6938666
OpenAlexW2995514232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.